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The main aims of this cross-sectional study were: (i) to 
assess the frequency of genital (vulval) lichen planus 
(VLP) and vulval lichen sclerosus (VLS) in women affect-
ed with oral lichen planus (OLP), regardless of the ge-
nital symptoms reported; and (ii) to verify whether any 
demographic, clinical, or histological features of OLP 
are associated with a higher risk of vulvo-vaginal involve-
ment. Fifty-five women, presenting OLP, consecutively 
underwent gynaecological examination and, if they 
demonstrated positive clinical signs of VLP, underwent 
biopsy. After a drop-out of 14 subjects, 31/41 (75.6%) 
were found to have signs of genital involvement, of which 
13/31 (44.0%) were asymptomatic. Following genital 
biopsy, 27/31 (87.1%) had histologically confirmed VLP 
or VLS. Following both univariate and multivariate 
statistical analyses, no significant association was found 
between gynaecological concomitance and demographic, 
clinical, histological features of OLP. This unpredictably 
common genital involvement in females with OLP em-
phasizes the importance of routinely performing both 
oral and gynaecological examinations, to facilitate an 
early and correct therapeutic approach. Key words: oral 
lichen planus; genital lichen planus.
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Lichen planus (LP) is one of the most common idiopathic 
immune disorders, found in 0.5–2.3% (1) of the general 
population. LP may involve, separately or simultaneously, 
different muco-cutaneous sites (oral and genital mucosa, 
skin, scalp and nail). The concurrent involvement of oral 
and genital sites, in patients with mucosal burning and 
itching, has been reported, especially in females, usually 
showing a low percentage (3.7–19.3%) of double involve-
ment for LP (2–4). 
It is common for women in the general population, 
to present to healthcare providers with the non-specific 
symptoms of persistent and recurrent oral and/or genital 
burning infection, oral lichen planus (OLP), burning 
mouth syndrome, or drug-related conditions. Similarly, 
genital burning may be attributed to candidosis (5), des-
quamative inflammatory vaginitis (6), or dysaesthetic 
vulvodynia (7). Collectively, these symptoms are often 
misdiagnosed, particularly since biopsies are not per-
formed on a regular basis (8). 
In 1869, Wilson (9) described a case of a woman with 
LP and “pruritus vaginae”; more recently, Gardner (10) 
and Lynch (11) reported a “desquamative inflammatory 
vaginitis” in association with erosive OLP. This asso-
ciation was recognized and defined as ”vulvo-vaginal-
gingival syndrome” (12) or ”plurimucosal LP” (13), and 
later its prevalence was established as between 3.7% 
and 19.3% in patients with OLP (2).
The main aims of this cross-sectional study were: (i) 
to evaluate the frequency of genital (vulval) LP (VLP) 
and vulval lichen sclerosus (VLS) in females affected by 
OLP; (ii) to verify whether any demographic, clinical, 
or histological features of OLP are associated with a 
higher risk of genital involvement.
PATIENTS AND METHODS
Between October 2001 and April 2004, following informed 
consent, female out-patients with clinical signs of oral liche-
noid lesions were consecutively enrolled after histological 
confirmation of OLP. Patients were excluded, if on the basis 
of histopathological features and clinical data, they were found 
to have lichenoid reactions to medications or a dental material 
(e.g. amalgam).
Oral examination and diagnostic criteria
Anamnestic and clinical data for each patient was recorded on 
a clinical report form. Examinations were carried out by one 
of the authors (ODF) as described previously (14–15). Clini-
cal features of OLP lesions were classified, as proposed by 
Rogers & Eisen (4), on the basis of the dominant variant into 
three forms: reticular, athrophic-erythematous, and ulcerative 
(including bullous) (Fig. 1). 
Gynaecological examination and diagnostic criteria
After the histological confirmation of OLP, all patients (with or 
without genital symptoms) were evaluated by a trained vulvo-
logist-gynaecologist (PB), as recommended by the European 
College for the Study of Vulval Diseases (ECSVD) (16). The 
Unexpectedly High Frequency of Genital Involvement in Women 
with Clinical and Histological Features of Oral Lichen Planus
Olga DI FEDE1, Pina BELFIORE2, Daniela CABIBI3, Stefano DE CANTIS4, Emiliano MARESI3, Alexander Ross KERR5 and
Giuseppina CAMPISI1
1Sector of Oral Medicine, Department of Oral Sciences, 2Institute of Gynaecology and Obstetrics, Mother and Children Department, 3Pathological 
Anatomy Institute 4Department of Social Statistic, University of Palermo, Palermo, Italy, and 5Department of Oral & Maxillofacial Pathology, Radiology, 
and Medicine, New York University College of Dentistry, New York, USA
434 O. Di Fede et al.
medical history, genital symptoms, clinical and histological data 
were collected and recorded on a vulvologist’s chart. Genital 
symptoms were described as itching, burning, dyspareunia, 
and/or vaginal discharge. Aided by vulvoscopy, genital signs 
were based on visual appearance (colour and surface changes) 
and palpation (texture and elasticity). Mons pubis, labia ma-
jora, labia minora, clitoris, vestibule, frenulum, perineum and 
perianal area were all examined closely. Genital lesions were 
defined as papular, erosive-atrophic or hypertrophic, according 
to the International Society for the Study of the Vulvovaginal 
Disease (ISSVD) (17). Examples of VLP and VLS are shown in 
Fig. 2. To reach histological confirmation of VLP, one or more 
biopsies were performed. In the presence of vaginal discharge 
from bacterial or candidal infection, a suitable treatment was 
given before performing biopsy. 
Histological procedures and characteristics
For diagnosis of OLP and VLP, formalin-fixed and paraffin-
embedded tissue sections were stained with haematoxylin-eosin 
and evaluated in a blinded manner by two pathologists (EM 
and DC). CD3 (pan T) and CD20 (pan B) immuno-stains were 
performed to confirm the predominance of T lymphocytes 
(CD3+) over B lymphocytes (CD20+), typical for LP (18–20); 
no assessment of sub-populations of T lymphocytes (CD4 or 
CD8) was routinely carried out. 
Each case had to meet the inclusion and exclusion crite-
ria. Cases were categorized as “histologically diagnostic of 
OLP/VLP” only when all three inclusion criteria were present 
(category 1); “compatible with OLP/VLP” when only two 
criteria were present (category 2) and “non consistent with 
OLP/VLP” when less than two criteria were evident (category 
3). Only patients classified in category 1 or 2 were included in 
the study. The inclusion criteria were: (i) signs of “liquefaction 
degeneration” in the basal cell layer; (ii) presence of well-
defined band of cellular infiltration, confined to the superficial 
part of the connective tissue; and (iii) strong predominance 
of T lymphocytes in the inflammatory infiltrate (Fig. 3 a). 
Each of these histological features was scored: 1=presence; 
0=absence. Although criteria used were originally established 
for OLP, in our study they were considered also for genital 
lesions, in the absence of criteria more recent than 1909 (21). 
Exclusion criteria were the following: (i) epithelial dysplasia 
(defined as presence of nuclear enlargement and hyperchroma-
tism, increased number of mitotic figures, aberrant mitoses, 
or dyskeratosis); (ii) absence of epithelial layers (for ulcers or 
erosions, inadequate sampling); (iii) deep extension of infiltra-
tion beyond superficial stroma; (iv) heterogeneous population 
in inflammatory infiltrate with B lymphocytes, neutrophils or 
plasma cells; (v) presence of lymphoid follicles in the infiltrate; 
or (vi) perivascular infiltration. 
Cases of VLS were included in the study when they met 
the following morphological features: (i) homogenization of 
the dermis with a band of scattered lymphocytes beneath; (ii) 
spongiosis of basal cell layer; or (iii) loss of rete ridges and 
thinning of the epithelium (Fig. 3b).
Statistics
Data were analysed by SPSS 10.0 (Chicago, IL, USA.). The χ2
test was used to assess statistical differences among categorical 
variables; Fisher’s exact test was used when the frequency 
Fig. 1. Examples of oral lichen planus of (a, b) the tongue and (c) buccae.
Fig. 2. Examples of (a) vulval lichen sclerosus and (b) 
vulval lichen planus.
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observed was less than 5; Student’s t-test was used for continuous 
variables; in all of evaluations p-values ≤ 0.05 were considered 
statistically significant. In particular, to measure the association 
level, crude odds ratio and the corresponding test-based 95% 
confidence interval were calculated. Reference groups were 
chosen as follows: for symptomatic category, the asymptomatic 
was chosen as the reference group; for ordinal variable (e.g. 
age) the first category was chosen as the reference group; for 
other features, the category with the largest number was chosen 
as the reference group. 
RESULTS
As shown in Fig. 4, 55 females were enrolled with clini-
cal signs of OLP (mean age 60.7 years, range 33–80 
years). In all, 14/55 (26%) patients were dropped from 
the study. The remaining 41 patients all had histologi-
cally confirmed OLP (83% were OLP category 1 and 
17% were OLP category 2). Of these 41 patients, 31 
showed clinical signs of genital lichenoid lesions. All 
31 patients underwent genital biopsy, and 27/31 patients 
(87%) showed histological confirmation of VLP, VLS, 
or both: 16/31 (52%) were VLP category 1, 6/31 (19%) 
were VLP category 2, 3/31 (10%) were VLS, and 2/31 
were both VLP and VLS. Four of 31 patients had other 
diseases. Those with genital involvement (VLP or VLS) 
showed a wide range in scores equated with degree of 
narrowing of the vaginal orifice.
After stratifying by whether they experienced genital 
symptoms, the demographic, clinical and histological 
features of the 41 patients, are shown for OLP and VLP/
VLS in Tables I and II, respectively. There were no sig-
nificant associations with the presence of VLP/VLS in 
terms of the demographic, clinical and histological fea-
tures of OLP, regardless of genital symptomatology.
Fig. 3. Histological features of (a) vulval 
lichen sclerosus and (b) genital lichen 
planus. Original magnification, a: 200×, 
b: 100×.
Fig. 4. Distribution of study population. OLP, oral lichen planus.
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Only one woman presented a pure “vulvo-gingival” 
form of LP, with exclusive involvement of both gingival 
and vulval sites.
Isolated gingival localization was found in only 3/27 
(11%) of patients.
DISCUSSION
LP is a muco-cutaneous disorder that can affect several 
body sites, showing a wide range of clinical variants 
and symptoms. Yet, a routine team approach by various 
specialists (i.e. oral medicine practitioner, gynaecolo-
gist and dermatologist) has not been adopted. Eisen 
(3) observed that in many OLP patients with genital 
symptoms, evaluation by physicians other than derma-
tologists, often led to misdiagnosis. Furthermore, diag-
nosis is rarely definitive when based on procurement of 
biopsy tissue and strict histological criteria. 
Since 1869 (9), when the first report appeared of a 
patient with LP in different mucosal sites, simultaneous 
involvement of different mucosal sites was taken into 
account. There are many case reports about simultan-
eous oral–genital involvement (4, 12, 13, 22–28), but 
only few systematic studies have reported prevalence 
data, with frequencies ranging from 3.7% to 19.3% 
(2–3). Notably, Eisen (3) identified, in a series of 399 
women with OLP, 77 cases (19.3%) of vulval and vaginal 
LP, presenting mainly with erosive or erythematous 
genital lesions. Interestingly, all of the 77 patients with 
genital involvement displayed gingival OLP; however, 
the severity and clinical oral variants were not cor-
related to the genital involvement. Ramer et al. (23) 
reported data regarding patients with severe oral lesions 
and a mild genital disease, as well as patients with 
asymptomatic gingival involvement but with severe 
erosive vulvo-vaginal disease. 
In the present study, authors assessed frequency of 
VLP/VLS (87.1%) in OLP patients and verified that there 
were no demographic, clinical or histological features 
of OLP that were significantly associated with genital 
disease. This was contrary to the reported association 
in the literature of vulvo-vaginal and gingival disease. 
Indeed, only a few cases of the vulvo-vaginal-gingival 
syndrome were found (11.1%), suggesting a casual 
association rather than a well-defined syndrome. 
As Eisen reported (3), sometimes this syndrome is 
not correctly recognized and the affected women suffer 
the lack of an appropriate medical therapy. Also, in our 
experience, the majority of women with genital symp-
toms reported a long history of such symptoms prior 
diagnosing the condition, suggesting a period of unsolved 
unspecified problems. Furthermore, all asymptomatic 
patients with VLS or/and VLP would have had no reason 
to consult a gynaecologist if not recruited for the study. 
In fact, unexpectedly, the highest frequency of genital 
lichen-like lesions was registered in the asymptomatic 
group (92.3%), but without any statistically significant 
difference, suggesting that lack of genital symptoms does 
not exclude per se the involvement of the district.
Previous studies have highlighted the need for histo-
logical evaluation in every case in which the features of 
the history and physical examination are suggestive of 
Table I. Features of oral lichen planus (OLP) patients included 
in the study (n=41)
Genital symptoms: Crude OR; (CI 95%)
No n (%) Yes n (%)
Total  18 (44)  23 (56)
Age (years) range  35–80  33–76
(mean ±SD), (62.8±11.7) (59±12)
HCV+  2 (11)  2 (9) 0.8 (0.1–6.0)
Dermal lichen planus  3 (17)  1 (4) 0.2 (0.0–2.4)
Oral histopathology: 
OLP1  16 (89)  18 (78) 2.2 (0.4–13.1)
OLP2  2 (11)  5 (22)
OLP location:
Gingival  11 (61)  16 (70) 1.5 (0.4–5.3)
Tongue  8 (44)  8 (35) 0.7 (0.2–2.4)
Buccal  15 (83)  18 (78) 0.7 (0.1–3.5)
Palate  7 (39)  6 (26) 0.6 (0.1–2.1)
OLP clinic:
AE  10 (56)  14 (61) 1.2 (0.4–4.3)
R  14 (78)  14 (61) 0.4 (0.1–1.8)
E  4 (22)  2 (9) 0.3 (0.1–2.1)
OR, odds ratio; SD, standard deviation; CI, confidence interval; HCV, 
hepatitis C virus; AE, atrophic-erythematous; R, reticular; E, erosive/
ulcerative/bullous
Table II. Features of genital involvement in patients grouped by 
symptoms (n=31)
Genital symptoms
No
n (%)
Yes
n (%)
p-value
Crude OR (CI 95%)
Total 13 (42) 18 (58)
Histopathological diagnosis
VLP1 8 (61) 8 (44)
VLP2 3 (23) 3 (17) p>0.2
VLS 1 (8) 2 (11)
VLP+VLS 0 (0) 2 (11)
Other disease 1 (8) 3 (17)
VLP/VLS location 
Clitoris 8 (62) 13 (72) 1.6 (0.4–7.4)
Fourchette/frenulum 7 (54) 11 (61) 1.4 (0.3–5.7)
Labia minor 13 (100)* 16 (89) 0.2 (0.0–2.1)
Labia maior 6 (46) 1 (6) 0.1 (0.0–0.7)
Perineum 3 (23) 3 (17) 0.7 (0.1–4)
Vestibule 8 (62) 10 (56) 0.8 (0.2–3.3)
Perianal 0 (0)* 2 (11) 2.5 (0.2–26.5)
VLP/VLS clinic 
AE 13 (100) 16 (89) 2.5 (0.2–26.4)
HY 4 (31) 8 (44) 0.6 (0.1–2.5)
P 1 (8) 0 (0) 2.9 (0.2–35.7)
OR, odds ratio; CI, confidence interval; VLP1, vulval lichen planus; 
VLP2, compatible with VLP; VLS, vulval lichen sclero-atrophicus; AE, 
atrophic-erythematous; HY, hypertrophic; P, papular.
*When a cell in a 2×2 table was equal to zero, a conventional value equals to 
0.5 was added to cell frequencies to allow the calculation of OR.
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LP (29). The histological diagnostic criteria of OLP were 
formulated first by the World Health Organization (WHO) 
(15) in 1978. However, strong inter- and intra-observer 
variability in the clinical and histological assessment of 
OLP, based on the WHO definition (30, 31) led to the 
development of more stringent diagnostic criteria (29), 
allowing a more reproducible diagnosis of OLP. Lotery 
& Galask (27) propose that the diagnosis of VLP may be 
based clinically on the presence of vulvo-vaginal signs 
alone, and the discovery of oral lesions is particularly 
supportive of this diagnosis. Additionally, they proposed 
that vulval or vaginal biopsy is generally non-contributory 
and may be misleading because, in presence of erosion, 
the histological features are variable. Conversely, in our 
experience described here, the diagnosis of LP (vulvo-
vaginal or oral) should always be confirmed by biopsy 
on the basis of a set of reproducible clinical and histopat-
hological criteria; and also, in doubtful cases, additional 
biopsies should be performed to establish the diagnosis. 
As mentioned above, many definitions have been 
proposed to describe a multifocal presentations of LP, from 
“vulvo-vaginal-gingival syndrome” (12), to “plurimucosal 
lichen planus” (13), to “oro-vaginal-vulvar lichen planus” 
(28). In our opinion, the term “plurimucosal lichen planus” 
used by Bermejo et al. (13) is appropriate only to describe 
the simultaneous (synchronous or metachronous) sites 
without specifying gingival or vaginal sites, since they are 
not always the areas affected. In fact, evaluation of our data 
(Tables I and II) suggests that no dominant site exists, and 
several sites may be involved at the same time. 
Regarding overlapping syndrome VLP/VLS, some 
authors (8, 32, 33) have suggested that these two aspects 
may represent a transitional stage to a unique disease 
rather than the coexistence of two distinct entities (8). 
In our opinion, differential diagnosis between VLP and 
VLS is difficult, particularly in the late stage of disease 
when fibrosis aspects, typical of VLS, are sometimes 
overlapping. Indeed both pictures are based on a similar 
immunological pathogenetic mechanism. 
This cross-sectional study shows a higher frequency 
of concomitant VLP or/and VLS in women with OLP 
than previously reported in the literature; yet stringent 
exclusion histological criteria were applied. On the 
basis of our data, we suggest that all women with any 
clinical variant of OLP, even in the absence of genital 
symptoms, should undergo a thorough multidisciplinary 
evaluation with a strict protocol for LP diagnosis. Even 
in the absence of genital signs, long-term surveillance 
of the same patients should be planned in order to 
prevent multi-site involvement and possible malignant 
transformation (34, 35).
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